Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Lasa Supergenerics Ltd - 540702 - Proceedings Of The Hon'Ble NCLT / Court Convened Meeting (CCM) Of Equity Shareholders

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015, as amended, we are submitting herewith the summary of proceedings of the Court Convened Meeting of the Company held on Saturday, June 12, 2021 at 10:30 A.M and commenced at 11:00 am Indian Standard Time ('IST') due to want of quorum, which then concluded at 11:45 am. (Including time allowed for e-voting at the CCM) through Video Conferencing/ Other Audio Visual Means ('VC/OAVM').
13-06-2021
Bigul

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Attached is the copy of Press Release titled 'LASA launches new product - Oxyclozanide Creating new Capacity as a brown field expansion' issued by the company.
09-06-2021

Earnings Call for Q4FY21 of Lasa Supergenerics

 Conference Call with Lasa Supergenerics Management and Analysts on Q4FY21 Performance and Outlook. Listen to the full earnings transcript.
04-06-2021

Lasa Supergener Standalone March 2021 Net Sales at Rs 39.10 crore, down 19.52% Y-o-Y

 NULL
03-06-2021
Bigul

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Attached is the copy of Press Release titled 'LASA SUPERGENERICS ANNOUNCES ROBUST PAT AT 22.80CRS, UP 521% YOY, with Recommendation of Dividend' issued by the company
01-06-2021
Bigul

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Friday, June 04, 2021 at 02:00 p.m. IST for discussing the Audited financial results of the Company for the quarter and financial year ended March 31, 2021.
01-06-2021
Bigul

Lasa Supergenerics Ltd - 540702 - Board recommends Final Dividend

 Lasa Supergenerics Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 31, 2021, inter alia, has recommendationof the final Dividend of Rs. 0.25 (2.5%) per equity share for the financial year ended March 31, 2021, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.
31-05-2021
Bigul

Lasa Supergenerics Ltd - 540702 - Results- Financial Year Ended March 31, 2021

 Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 11:00 am and concluded at 01:30 p.m. inter- alia have considered and approved the following: 1. The Audited Financial Results of the Company for the Quarter and financial Year ended March 31, 2021. 2. Recommendation of the final Dividend of Rs 0.25 (2.5%) per equity share for the financial year ended March 31, 2021, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. A copy of the statement of audited Financial Results, Cash Flow statement along with Audited Report submitted by the Statutory Auditors of the Company is attached herewith.
31-05-2021
Bigul

Lasa Supergenerics Ltd - 540702 - Outcome Of Board Meeting Held Today I.E. May 31, 2021

 Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 11:00 am and concluded at 01:30 p.m. inter- alia have considered and approved the following: 1. The Audited Financial Results of the Company for the Quarter and financial Year ended March 31, 2021. 2. Recommendation of the final Dividend of Rs 0.25 (2.5%) per equity share for the financial year ended March 31, 2021, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.
31-05-2021
Bigul

Lasa Supergenerics Ltd - 540702 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to SEBI Circular CIR/CFD/CMD1/27/2019 dated 8th February, 2019, please find enclosed copy of the of Annual Secretarial Compliance Report dated May 27, 2021 issued by Shivam Sharma & Associates, for the financial year 2020-2021.
28-05-2021
Next Page
Close

Let's Open Free Demat Account